Long Drug Therapy After Stents Provokes Reassessment
A large study suggests extending anti clotting therapy beyond one year after drug coated stents lowers major heart complications, while increasing bleeding risk. Results challenge the move toward shorter treatment and prompt FDA scrutiny.
MENTIONED IN THIS ARTICLE
Chicago
Europe
Patrick O’gara
Brigham and Women’s Hospital
Boston
American College of Cardiology
Brigham
Laura Mauri
Federal Food and Drug Administration
American Heart Association
New England Journal of Medicine
FDA
Mauri
Mary Ross Southworth
Harvard University
O'Gara
Also Mentioned on This Page
Lorain County
AccuWeather.com
Shawn
Tade
Avon Lake
Sandusky
Bellevue
Lake Erie
Willard
Huron
Norwalk
Shiloh
New London
Loral Amherst A
Oberlin
Wellington
Elyria
Lake
Ane
Woo
Cleveland
Parma
Py Heights
Grafton” Sia
Lodi
Bailey Lakes
Creston
Doylestown
Tom
Aspen Cancun
Daytona Beach
Honolulu
Jacksonville
Key West
Las Vegas
Miami
Oot
Montego Bay
Myrtle Beach
Nassau
Oranjestad
Aruba
Orlando
Palm Springs
Puerto Vallarta
Punta Cana
Rio de Janeiro
San Juan
Tahiti
Tampa
World Cities Today
Beirut
Berlin
Buenos Aires
Cairo
Calgary
Dublin
Hong Kong
Jerusalem
Lisbon
New Delhi
Paris
Rome
Seoul
Singapore Sydney
Tokyo
Toronto
Sf Warsaw
Tegra
AccuWeather, Inc
Atlanta
Memphis
Atlantic City
Milwaukee
Baltimore
Minneapolis
Birmingham
Nashville
Boise
New Orleans
New York City
Charleston
Norfolk
Oklahoma City
Po el Paso
Ats St. Louis
Pe A
Erie
Salt Lake City
Fairbanks
As A
San Diego
Houston
San Francisco Ce
Po Ar
Santa Fe
Huntington
Indianapolis
Pc A
Seattle
Toledo
Kansas City
Little Rock Ag
Topeka
Los Angeles
Tucson
Louisville
Washington
Pe-Parly Clouny
Sidney C. Smith Jr
Heart Association
University of North Carolina At Chapel Hill
Boston Scientific
Carol Gallardo
Five Oaks —— Realty
Ran Aceo Ery Solem
Reliabledrain.com
Griswold Rd
Sasi
Ree Ric
Dain
Wun
BluestarRecycling.com
BSG Te Ss
Bluestar
Hane
Brea
Freeday
E. Broad Street
Broad
Lopen
Dar
Connie Schultz
the Chronicle